mRNA |
PF-543 |
CTRPv2 |
pan-cancer |
AAC |
-0.0059 |
0.9 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.0086 |
0.9 |
mRNA |
paclitaxel |
CCLE |
pan-cancer |
AAC |
0.0068 |
0.9 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
-0.0052 |
0.9 |
mRNA |
BMS-708163 |
GDSC1000 |
pan-cancer |
AAC |
-0.005 |
0.9 |
mRNA |
GSK525762A |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
mRNA |
JW-55 |
CTRPv2 |
pan-cancer |
AAC |
0.011 |
0.9 |
mRNA |
Y-39983 |
GDSC1000 |
pan-cancer |
AAC |
-0.0045 |
0.9 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0047 |
0.9 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0049 |
0.9 |